Stencel, K. M., Czyżewicz, G., Jankowski, T., Stryjkowska-Góra, A., Zajda, K., Kowal, J. L., Brudny-Borowska, B., Sliwinski, P., Wojda, E., Majewska, E., Ramlau, R., Kowalski, D. M. (2025). Real-world baseline characteristics and diagnostic path of Polish patients with ALK-positive NSCLC eligible for brigatinib treatment: Interim results from the ENTIRETY study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e20640